Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | revenue | rating |
---|---|---|---|---|---|---|---|
Acumen Pharmaceuticals, Inc. | $2.37 | $157.41 M | -2.5 | 51 | $0 | ||
Amylyx Pharmaceuticals, Inc. | $1.77 | $120.37 M | -1.65 | 384 | $380.79 M | ||
Apellis Pharmaceuticals, Inc. | $35.41 | $4.90 B | -11.77 | 702 | $396.59 M | ||
Bolt Biotherapeutics, Inc. | $0.74 | $29.02 M | -0.46 | 100 | $7.88 M | ||
Coherus BioSciences, Inc. | $1.39 | $193.89 M | -2.28 | 249 | $257.24 M | ||
Day One Biopharmaceuticals, Inc. | $13.50 | $1.12 B | -5.11 | 174 | $0 | ||
Design Therapeutics, Inc. | $3.19 | $217.51 M | -3.7 | 57 | $0 | ||
Erasca, Inc. | $2.18 | $647.94 M | -2.83 | 126 | $0 | ||
Monte Rosa Therapeutics, Inc. | $3.89 | $243.38 M | -1.59 | 130 | $0 | ||
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 | ||
Icosavax, Inc. | $15.31 | $769.04 M | -6.96 | 60 | $582,000 | ||
Inozyme Pharma, Inc. | $4.49 | $286.39 M | -3.43 | 59 | $0 | ||
Mirum Pharmaceuticals, Inc. | $33.88 | $1.18 B | -6.7 | 278 | $186.37 M | ||
Mirati Therapeutics, Inc. | $58.70 | $4.12 B | -4.82 | 587 | $12.44 M | ||
Neoleukin Therapeutics, Inc. | $3.49 | $8.20 M | -0.28 | 7 | $0 | ||
Spero Therapeutics, Inc. | $1.33 | $75.85 M | 3.19 | 46 | $96.74 M | ||
Terns Pharmaceuticals, Inc. | $6.86 | $462.44 M | -5.67 | 66 | $0 | ||
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 | ||
VectivBio Holding AG | $16.87 | $1.06 B | -8.03 | 0 | $27.34 M | ||
X4 Pharmaceuticals, Inc. | $0.56 | $169.62 M | -1.51 | 116 | $0 |